Screening
-
Targeted substances
- Triglyceride
- Bilirubin
- Carbamazepine
- Digoxin
- Methotrexate
- Bile acid
- Paraquat
- Myoglobin
- Cholesterol
- Inflammatory Mediators and Cytokines
- Leptin
- Ammonia
- Protein-bound toxins
- β2-MG
- Organophosphate
- PTH
- Rivaroxaban
- 2,4-Dinitrophenol
- Ticagrelor
- Paracetamol
- Metformin
- ANA and ds-DNA Titers
- Abrin
- Sodium Valproate
- Amlodipine
- Estazolam
- Quetiapine
- Olanzapine
- Ziprasidone
- Vancomycin
- Organophosphorus
- Circulating Bacteria
- Liver Enzymes(e.g. ALT,AST)
- Vancomycin
- Gentamicin
- Poison
- Protein Binded Substance
- Antimicrobials
- Plasma-free hemoglobin(PfHb)
- Uremic Toxins
- Amylase
- Creatine Kinase(CK)
- C-Reactive Protein(CRP)
- Others
- Antithrombotics
- Calcium Channel Blocker (Amlodipine)
- Lactate
- Ammonia
-
Benefits
- Improve QOL
- Decrease Vasopressor Needs
- Stabilize Hemodynamics
- Improve Oxygenation
- Bridge to Liver Transplantation
- Reduce the Incidence of Adverse Effect
- Shorten ICU Stay
- Reduce Bleeding Complications
- Reduce Mechanical Ventilation
- Improve Respiratory Function
- Lower the Mortality Rate
- Improve Liver Function
- Improve Sleep Efficiency
- Improve HE
- Improve Renal Function
- Relieve Uremic Pruritis
- Reduce Cardiovascular Related Events
- Improve Survival Rate
- Remove Inflammatory Markers/ Cytokines
- Reduce Circulating Bacterial Load
- Improve Disease Symptoms
- Improve Laboratory Parameters
- Cost Effectiveness
- Others
- Disease
- Endocarditis
- Poisoning/Drug Overdose
- Leptospirosis
- Sepsis/ Septic Shock
- Multiple Myeloma
- Severe Acute Pancreatitis(SAP)
- Multiple Organ Dysfunction Syndrome(MODS)
- Rhabdomyolysis
- Dengue
- Leukemia-Sepsis
- Burn
- Trauma
- Open Heart Surgery
- Acute Respiratory Distress Syndrome (ARDS)
- Hepatic Encephalopathy(HE)
- End Stage Renal Disease(ESRD)
- Acute Kidney Injury(AKI)
- Systemic Lupus Erythematosus (SLE)
- Liver Transplantation
- Liver Failure(LF)
- Jaudice
- Subarachnoid Hemorrhage
- Symmetrical Peripheral Gangrene(SPG)
- Wasp Stings
- Acute Renal Failure
- Hepatitis
- Cardiopulmonary Bypass(CPB)
- Severe Liver Injury
- Henoch-Schönlein Purpura (HSP)
- COVID-19
- Polymyositis
- Liver Cirrhosis
- Hyperbilirubinemia
- Maintenance Hemodialysis (MHD)
- Crush Syndrome
- Human Immunodeficiency Virus(HIV)
- Immunological Diseases (IMD)
- Hyperlipidemia
- Infection
- Others
- Acute Type A Aortic Dissection (ATAAD)
- Autoimmune Hepatitis (AIH)
- Chronic Hepatitis C (HCV)
- Cancer-Related Complications
- Cardiogenic Shock
-
Efficacy of DPMAS combined with PE in improving survival outcomes of patients with acute hepatitis E-induced liver failure: A retrospective cohort analysis
Tang R, Ji Y, Yao H, et al. [J]. iLIVER, 2025: 100203.
-
Effects of combined haemodialysishaemoadsorption therapy in maintenance haemodialysis patients: study protocol for a multicentre, openlabel, randomised, parallel controlled trial
Huang W, Zhang L, Wu H, et al. [J]. BMJ open, 2025, 15(11): e107017.
-
Hemoadsorption in Postoperative Heart Transplant Patients or Cardiogenic Shock Patients on VA-ECMO
Angie Giselle Otalvaro-Pechene, Edgardo Quiñones, et al. [J]. Salutem Scientia Spiritus, 2025.
-
Prognostic value of inflammatory cytokine levels, clinical efficacy, and prognosis of the hybrid artificial liver support system in chronic liver failure treatment
Liu L, Li X, Wang J, et al. [J]. Journal of Medical Biochemistry, 2025, 44(7): 1429.
-
Comparative Cost-Effectiveness of Two Artificial Liver Therapies in Early-Stage Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Retrospective Cohort Study
Chen J, Luo Q, Wang L, et al. [J]. Therapeutics and Clinical Risk Management, 2025: 1095-1105.
-
Enhanced cognitive outcomes with triple-mode dialysis in kidney failure: role of protein-bound toxin clearance
Wang M, Hua W, Chen L, et al. [J]. Renal Failure, 2025, 47(1): 2590874.
-
Effect of extracorporeal membrane oxygenation combined with hemoperfusion on inflammatory factors in patients with cardiogenic shock
Hao JY, Wang SF, Yang Q, et al. World J Cardiol. 2025;17(8):109903. doi:10.4330/wjc.v17.i8.109903
-
Hemoadsorption contribution in neonatal cardiac surgery
Molinari I, Aidala E, Cascarano MT, et al. Front Cardiovasc Med. 2025;12:1615697. Published 2025 Sep 17. doi:10.3389/fcvm.2025.1615697
-
Removal of Psychotropic Drugs by Hemoadsorption with the HA380 Cartridge
Furukawa T, Lankadeva Y R, Baldwin I C, et al. [J]. Blood Purification, 2025.
-
Effectiveness of haemodialysis with hemoperfusion therapeutic modality in paediatric chronic kidney disease
Widiasta A, Rossanti R, Rachmadi D, Hilmanto D.. Med Glas (Zenica). 2025 Aug 25;22(2):304-310. doi: 10.17392/1906-22-02. PMID: 41082758.
-
Clinical Experience of Combining Single-Use HA130 Hemoadsorption Cartridge with High-Flux Hemodialysis in Maintenance Hemodialysis Patients
L.A. Fedotova, N.V. Shchekotikhina, M.A. Ershova, E.I. Gryaznova. 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology,2025
-
The use of hemoadsorption in cancer-related complications
Premuzic V, Forni L G. [J]. Blood purification, 2025.
-
Extracorporeal hemoadsorption and neurological disorders: A challenging perspective
J Transl Crit Care Med 2025;7:e25-00015
-
ADSORPTION KINETICS OF β2-MICROGLOBULIN AND PARATHYROIDHORMONE BY ADSORBENT MATERIAL A 12-HOUR IN VITRO PROFILINGSTUDY
Hu Liu , Zixun Liu . 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology, 2025
-
Hemoadsorption Combined with Hemodialysis and the "Inflammation Mitigation Hypothesis"
Alessandra B, Anna L, Ronco C, et al. [J]. Integr Med Nephrol Androl,2024, 11:e00006.
-
Comparative Efficacy of pHA130 Haemoadsorption Combined with Haemodialysis Versus Online Haemodiafiltration in Removing Protein-Bound and Middle-Molecular-Weight Uraemic Toxins: A Randomized Controlled Trial
S Yu, H Yuan, X Xiong, Y Zhu, P Fu, Toxins, 2025•mdpi.com
-
Chinese Expert Guidance on Critical Care Hemoadsorption (2025)
Wang C, Liu S, Zheng Y, et al. [J]. Journal of Translational Critical Care Medicine, 2025, 7(3): e25-00011.
-
HEMOADSORPTION IN SODIUM FLUOROACETATE POISONING: CASE REPORTS
-
Endotoxin and cytokine removal with a new (CA) sorbent cartridge
Lorenzin A, Perin N, de Cal M, et al. [J]. Blood Purification, 2025.
-
From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research
Cozzolino, Mario, Lorenza Magagnoli, and Paola Ciceri. Toxins 17.6 (2025): 295.


